Safety and effectiveness of psilocybin therapy for alcohol use disorder in an extended open-label trial

Psilocybin-assisted therapy (PAT) for alcohol use disorder (AUD) shows promise in randomized controlled trials.

• PAT may provide efficacy outcomes for patients with AUD in earlier blinded treatments.
• The open-label extension aims to evaluate additional benefits from subsequent psilocybin administration.
• Safety outcomes are being assessed alongside efficacy in this Phase II randomized controlled trial.

Simplified